Neuro-navigation Systems Market Size, Share | Report 2022-2030
The global neuro-navigation systems market was valued at USD 1856.04 Million in 2021 and it is predicted to surpass around USD 4465.2 Million by 2030 with a CAGR of 10.25% from 2022 to 2030.
Market Synopsis
Neuro-navigation also called frameless stereotactic surgery which involves performing real-time intraoperative guidance during spinal/brain injuries. This system enhances safety and accuracy during neurosurgical procedures and helps surgeons achieve surgical targets without the need for external. Neuro-navigation systems are primarily used in brain surgery to limit the size of the cranial opening or craniotomy, and help remove deep brain lesions. It also assists psychiatrists to precisely target rTMS (Transcranial Magnetic Stimulation). Such factors are likely to drive the demand for the neuro-navigation systems market in the near future.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 1856.04 Million |
| Revenue Forecast by 2030 | USD 4465.2 Million |
| Growth rate from 2022 to 2030 | CAGR of 10.25% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Type, Application, End-Users, Region |
| Companies Covered |
Neuro-navigation Systems market include Northern Digital Inc., ClaroNav, Medtronic, Stryker, BrainLAB AG, Synaptive Medical, Soterix Medical Inc., Stryker, Nexstim Plc, 7D Surgical, Zimmer Biomet Holding Inc., and Parsis Co. and other players |
Market Influencer
Growing incidence of neurological disorders such as cancer, benign tumors, and stroke as well as rising adoption of minimally invasive surgical procedures are the key growth drivers for the global neuro-navigation systems market. Furthermore, the demand for neuro-navigation systems is expected to grow as the number of neurosurgical procedures being performed worldwide increases. For instance, as per the American Cancer Society, in 2022 , approximately 25,050 malignant tumors of the brain or spinal cord (14,170 in men and 10,880 in women) will be diagnosed in the U.S. and around 18,280 people will die from the same illness.Thus, the rise in the number of people suffering from brain tumors and related conditions leading to brain metastasis is expected to propel the demand for neuro-navigation systems during the forecast period.
Furthermore, an increasing number of approvals and new product launches are expected to further drive the market growth over the forecast period. The introduction of new and innovative products by key market players is fuelling the demand and adoption of these systems in the global market. Advancements in technology such as improved accuracy due to improved software and registration processes, as well as the less complicated framework is expected to propel the growth of the neuro-navigation systems market. For instance,
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Neuro-navigation Systems Market
5.1. COVID-19 Landscape: Neuro-navigation Systems Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Neuro-navigation Systems Market, By Type
8.1. Neuro-navigation Systems Market, by Type, 2022-2030
8.1.1 Optical System
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Electromagnetic System
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Neuro-navigation Systems Market, By Application
9.1. Neuro-navigation Systems Market, by Application, 2022-2030
9.1.1. Neurosurgery
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. ENT Surgery
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Maxillofacial Surgery
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Spinal Surgery
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Neuro-navigation Systems Market, By End-Users
10.1. Neuro-navigation Systems Market, by End-Users, 2022-2030
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Ambulatory Surgery Centres
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Other
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Neuro-navigation Systems Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type (2017-2030)
11.1.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.4.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.4.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.4.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.4.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.4.3. Market Revenue and Forecast, by End-Users (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.3. Market Revenue and Forecast, by End-Users (2017-2030)
Chapter 12. Company Profiles
12.1. Neuro-navigation Systems market include Northern Digital Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. ClaroNav
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Medtronic
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Stryker
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. BrainLAB AG
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Synaptive Medical
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Soterix Medical Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Stryker
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Nexstim Plc
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. 7D Surgical
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers